Four Drugs Top Three for Upfront Treatment of Multiple Myeloma
Adding anti-CD38 antibodies boosts response and PFS, but timing, sequencing, cost questioned
Stay updated with breaking news from Dan Vogl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adding anti-CD38 antibodies boosts response and PFS, but timing, sequencing, cost questioned
/PRNewswire/ -- The Mark Foundation for Cancer Research announced 16 outstanding projects in its latest class of ASPIRE awards, granting more than $5 million...
Modakafusp alfa, a first-of-its-kind drug has shown early potential in combating multiple myeloma, a form of bone marrow cancer, according to a latest study.
A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a study presented by researchers from the University of Pennsylvania's Abramson Cancer Center at the 2022 American Society of Hematology Annual Meeting (Abstract 565).
A first-of-its-kind drug known as modakafusp alfa has shown early potential in combating multiple myeloma, a form of bone marrow cancer, in a study presented by researchers from the University of...